Disc Medicine, Inc. - COMMON STOCK (IRON)

Q1 2023 13F Holders as of 3/31/2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
34.8M
Number of holders
45
Total 13F shares, excl. options
14.6M
Shares change
+3.64M
Total reported value, excl. options
$310M
Value change
+$77.1M
Number of buys
27
Number of sells
-6
Price
$21.19

Significant Holders of Disc Medicine, Inc. - COMMON STOCK (IRON) as of Q1 2023

47 filings reported holding IRON - Disc Medicine, Inc. - COMMON STOCK as of Q1 2023.
Disc Medicine, Inc. - COMMON STOCK (IRON) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14.6M shares of 34.8M outstanding shares and own 41.99% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (3.46M shares), Novo Holdings A/S (2.34M shares), ORBIMED ADVISORS LLC (2.27M shares), Bain Capital Life Sciences Investors, LLC (1.99M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (827K shares), 5AM Venture Management, LLC (588K shares), Logos Global Management LP (525K shares), VANGUARD GROUP INC (323K shares), Rock Springs Capital Management LP (313K shares), and Foresite Capital Management V, LLC (244K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.